Showing 1 - 12 results of 12 for search 'Samuel Aballéa', query time: 0.07s Refine Results
  1. 1
    Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al

    Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al by Mondher Toumi, Samuel Aballea

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Measuring health-related quality of life in young children: how far have we come?

    Measuring health-related quality of life in young children: how far have we come? by Nicola Germain, Samuel Aballéa, Mondher Toumi

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe

    On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe by Katarzyna Jabłońska, Samuel Aballéa, Pascal Auquier, Mondher Toumi

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results

    Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results by Junwen Zhou, Aurélie Millier, Clément François, Samuel Aballéa, Mondher Toumi

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review

    Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review by Bérengère Macabeo, Arthur Quenéchdu, Samuel Aballéa, Clément François, Laurent Boyer, Philippe Laramée

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach

    Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach by Ru Han, Shuyao Liang, Clément François, Samuel Aballea, Emilie Clay, Mondher Toumi

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

    Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies by Michal Pochopien, Annette Beiderbeck, Phil McEwan, Richard Zur, Mondher Toumi, Samuel Aballéa

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK

    Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK by Zalmai Hakimi, Con Kelleher, Samuel Aballéa, Khaled Maman, Jameel Nazir, Colette Mankowski, Isaac Odeyemi

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Analysis of health economics assessment reports for pharmaceuticals in France - understanding the underlying philosophy of CEESP assessment

    Analysis of health economics assessment reports for pharmaceuticals in France - understanding the underlying philosophy of CEESP assessment by Mondher Toumi, Anastasiia Motrunich, Aurélie Millier, Cécile Rémuzat, Christos Chouaid, Bruno Falissard, Samuel Aballéa

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models

    An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models by Michał Pochopień, Ewelina Paterak, Emilie Clay, Justyna Janik, Samuel Aballea, Małgorzata Biernikiewicz, Mondher Toumi

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  11. 11
    Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease

    Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease by Michal Pochopien, Jakub Wladyslaw Dziedzic, Samuel Aballea, Emilie Clay, Iwona Zerda, Mondher Toumi, Borislav Borissov

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  12. 12
    Health economic evaluation of gene replacement therapies: methodological issues and recommendations

    Health economic evaluation of gene replacement therapies: methodological issues and recommendations by Samuel Aballéa, Katia Thokagevistk, Rimma Velikanova, Steven Simoens, Lieven Annemans, Fernando Antonanzas, Pascal Auquier, Clément François, Frank-Ulrich Fricke, Daniel Malone, Aurélie Millier, Ulf Persson, Stavros Petrou, Omar Dabbous, Maarten Postma, Mondher Toumi

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: